Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021

Nesrin Ghanem-Zoubi1Comments to Author , Yafit Atiya-Nasagi1, Evgeniy Stoyanov, Moran Szwarcwort, Basel Darawsha, Mical Paul, and Eilat Shinar
Author affiliations: Rambam Health Care Campus, Haifa, Israel (N. Ghanem-Zoubi, M. Szwarcwort, M. Paul); The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa (N. Ghanem-Zoubi, B. Darawsha, M. Paul); Israel Institute for Biological Research, Ness-Ziona, Israel (Y. Atiya-Nasagi); Magen David Adom National Blood Services, Ramat Gan, Israel (E. Stoyanov, E. Shinar)

Main Article

Table 3

Risk factors for Q fever seropositivity and results of univariate and multivariate analyses in cross-sectional study of Q fever seroprevalence among blood donors, Israel, 2021*

Parameter All participants, N = 1,473 Seropositive, n = 188 Seronegative, n = 1,285 Univariate analysis p value Multivariate analysis
Odds ratio (95% CI) p value
Mean age +SD, y
 36.6 +13.9
 41.1 +13.3
 35.9 +13.9
 <0.001
 1.2 (1.01–1.03)
 <0.001
Male sex
 859 (58.3)
 128 (68.1)
 731 (56.9)
 0.004
 1.6 (1.1–2.2)
 0.005
Born in Israel
 1,211 (82.9)
 153 (81.3)
 1,058 (83)
 0.677
Living in Jewish locality
 1,310 (89.3)
 167 (88.8)
 1,143 (89.4)
 0.824
Rural locality
372 (25.4)
 38 (20.2)
 334 (26.1)
 0.082
Socioeconomic status of residence localities 0.683
Low 328 (22.5) 39 (20.9) 289 (22.7)
Moderate 714 (49.0) 94 (50.3) 620 (48.8)
High
 416 (28.5)
 54 (28.9)
 362 (28.5)
Living in coastal plain 629 (42.9) 100 (53.2) 529 (41.4) 0.002 1.6 (1.2–2.3) <0.001

*Values are no. (%) except as indicated. †<5,000 population.

Main Article

1These authors contributed equally to this article.

Page created: March 07, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external